Academic Editor: Indrajit Chowdhury
Introduction: Myocardial infarction is the leading cause of death in
women worldwide. Several studies have shown that estrogens play a
cardioprotective role in women by decreasing reactive oxygen species (ROS) and
increasing nitric oxide (NO). The aim of this work was to determine whether the
evolution of myocardial infarction depends on the phase of the estrous cycle.
Methods: Female Wistar rats were randomized into the following groups
with an (n = 7 per group): (1) ovariectomized (OVX-sham); (2) OVX-48 h coronary
occlusion (CO); (3) OVX-2 w CO; (4) proestrus-sham; (5) proestrus-48 h CO; (6)
proestrus-2 w CO; (7) estrus-sham; (8) estrus-48 h CO; and (9) estrus-2 w CO. We
measured the percentage of myocardial necrosis, cardiac hypertrophy, hemodynamic
parameters, and the production of NO and ROS, after acute and chronic myocardial
infarction was induced in proestrus or estrus or ovariectomized female rats.
Results: The infarct area was reduced in the proestrus groups, while it
was increased in the estrus and OVX groups. The left ventricular systolic
pressure (LVSP) and
For many years, there has been a lack of investigations on cardiovascular diseases (CVD) in female subjects. Furthermore, gender differences have been neglected in the diagnosis and treatment of these conditions; consequently, there is an alarming increase in the incidence of CVD among women, including myocardial infarction (MI) [1, 2].
In general terms, women’s mortality due to myocardial infarction has not been thoroughly considered or studied in depth. Globally, 521,900 deaths due to breast cancer were reported [3]; while 12.59 million deaths due to CVD occurred in the same year [4]. In addition, in clinical practice, there is a history of misdiagnosis and mistreatment of myocardial infarction in women [1]. This fact can be explained in part by the lower incidence of MI among premenopausal women compared to men of the same age, whereas the mortality rate in postmenopausal women is similar to or even exceeds that of men. This marked difference is attributed mostly to the role of sex hormones [5]. There is a body of evidence supporting that sex hormones play a cardioprotective role in young women.
Several studies have tested the cardioprotective effect of estrogens. However, few investigations [6] have associated the phases of the estrous cycle with MI. Most of the studies have simply focused on the presence or absence of hormones, but not on the physiological variation in premenopausal hormone levels. For instance, some clinical trials have shown that estrogen or estrogen-progesterone therapies in pre- and post-menopausal women have had no significant effect on preventing MI, while others demonstrated an association of low endogenous levels of estrogens and high levels of testosterone with cardiovascular risk and death [7, 8, 9, 10, 11].
17
Three different isoforms of NO synthase (NOS) can generate NO. Neural NOS (nNOS) and endothelial NOS (eNOS) are expressed constitutively in neurons and endothelial cells, but can also be expressed in other cells and are related to cardiovascular homeostasis. These NOS are calcium-dependent and generate nanomolar concentrations of NO. Inducible NOS (iNOS), on the other hand, was discovered in macrophages and it has been related to inflammatory stages activated by cytokines; once activated, iNOS generates large quantities of NO [16]. Within this context, NO may have antiapoptotic, antihypertrophic, and cellular protective effects and may participate in cardiac muscle contraction [17, 18]. Also, it has been reported that an increase in stress factors such as ROS has been reported to influence the evolution of MI since these chemical species participate in cell damage signaling, necrosis and cellular apoptosis through their oxidizing effects on macromolecules such as lipids and proteins [19].
Therefore, this work aimed to determine whether the evolution of MI depends on the phase of the estrous cycle. To demonstrate this, we measured the percentage of myocardial necrosis, cardiac hypertrophy, hemodynamic parameters, and the production of NO and ROS after acute and chronic MI was induced during proestrus or estrus and compared the results to ovariectomized female rats.
Female Wistar rats (12 to 13 weeks old) were obtained from the CINVESTAV-IPN Unidad Sur animal facility. All animal procedures were conducted according to Federal Regulation for Animal Experimentation and Care (SAGARPA, NOM-062-ZOO, 1999, Mexico), local ethics committee number C18_06 (CICUAE-FESC), and National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978, USA). Animals were randomized into the following groups: (1) ovariectomized (ovx)-sham; (2) ovx-48 h coronary occlusion (CO); (3) ovx-2 w CO; (4) proestrus-sham; (5) proestrus-48 h CO; (6) proestrus-2 w CO; (7) estrus-sham; (8) estrus-48 h CO, and (9) estrus-2 w CO. In the ovariectomized groups, the animals were allowed to recover for 5 weeks after bilateral ovariectomy before CO. Forty-eight hours or 2 weeks after CO surgery, catheterization was performed, plasma samples were obtained to quantify sex hormones, the left ventricular penumbra area was removed to measure NO by the Griess reaction, and ROS were quantified by electronic paramagnetic resonance (EPR).
Rats were anesthetized using pentobarbital (55 mg/kg i.p.) and subjected to bilateral ovariectomy as previously reported [20]. The same procedure, except for removal of the ovaries, was performed in the control (sham) group. All animals received postoperative analgesia with 0.1 mL of tramadol and topical erythromycin. At the end of the experiment, the uterus was removed, weighed and normalized to body weight for the evaluation of hormone depletion.
A vaginal smear was obtained to allocate the females to the estrus and proestrus
groups in order to perform CO during the correct estrous phase (CO) [21]. A cannula with saline solution was gently and quickly inserted into the vaginal
orifice; the introduction was shallowed (approximately 1 cm) to avoid cervical
stimulation. Subsequently, a small amount of vaginal fluid was suctioned. Rats
were not anesthetized during smear collection. The collected sample of epithelial
cells was placed on a slide, dried at 37
Rats were anesthetized by i.p. administration of 40 mg/kg ketamine + 5 mg/kg xylazine. A thoracotomy was performed between the 4th and 5th intercostal space to exteriorize the heart, and breathing support was administered simultaneously. The left anterior coronary artery was located and ligated with an atraumatic needle and 5/0 silk thread. The heart was returned to the thoracic cavity. All animals were allowed to recover and received analgesics and topical erythromycin [22]. The animals were randomly allocated to the 48-h group or 2-week group.
At the end of each experiment, the animals were euthanized by cervical dislocation. The heart was cut into 2 mm sections and stained with 0.1% nitrotetrazolium blue chloride (NBT, Sigma Aldrich N6876) for 15 min to differentiate the non-infarcted (red tissue) from the infarcted area (white tissue). The infarcted area was calculated as the percentage of the total area of the left ventricle by densitometry using image processing software (Adobe® Photoshop CC 2019 20.0.10, Michigan, USA) and is expressed in arbitrary units. The evaluation was carried out in a blinded fashion.
This parameter was calculated by the following formula: WIx = Wx/Wc, where WIx = wet weight index of the corresponding chamber; Wx = wet weight of the chamber, and Wc = animal body weight.
Forty-eight hours or 2 weeks after CO, the animals were anesthetized by i.p. administration of 35 mg/kg sodium pentobarbital. A tracheotomy was performed, and the right carotid artery was dissected and cannulated with a heparinized PE-10 catheter connected to a pressure transducer (Biopaq Systems, Santa Barbara California, USA). The catheter was inserted into the left ventricle to measure the left ventricular systolic pressure (LVSP), left ventricular diastolic pressure (LVDP), and the maximum range of isovolumetric pressure (+dP/dtmax) and decay (–dP/dtmax) as well as heart rate (HR) [23].
After the hemodynamic data experiments, blood samples were collected and serum was obtained to measure estradiol and progesterone levels using a commercial kit, following the manufacturer’s specifications (Monobind Inc. ELISA Kit®, Lake Forest, California, USA).
NO was quantified by the Griess method. Briefly, 100 mg of the left ventricle
penumbra was used. The tissue was homogenized in 500
Krebs/Hepes buffer (88.6%/1.4% w/v) containing 156.17 nM of 3.15%
diethyldithiocarbamate acid silver salt (DETC) and 3.045
Data are reported as mean
To confirm the effects of ovariectomy, we weighted the uterus of all experimental animals (Table 1). Atrophy in the OVX group was confirmed by the absence of sex hormones after removal of the ovaries.
Group | Weight index (%) |
OVX | 0.04 ± 0.006 |
proestrus | 0.18 ± 0.05* |
estrus | 0.21 ± 0.01* |
Uterus weight index was higher in proestrus-sham and estrus-sham vs
OVX-sham females (* p |
To study the effect of the presence or absence of sex hormones at the time of
MI, 17-
Estradiol during proestrus diminishes the infarcted area. (A)
17-
Cardiac Chambers (mg/g) | |||||
Group | Oclussion time | LV | RV | LA | RA |
sham | 1.70 ± 0.09 | 0.86 ± 0.08 | 0.09 ± 0.01 | 0.07 ± 0.01 | |
OVX | 48 h | 1.79 ± 0.18 | 0.56 ± 0.04 | 0.11 ± 0.01 | 0.06 ± 0.01 |
2 w | 1.43 ± 0.05 | 0.91 ± 0.03 | 0.09 ± 0.00 | 0.06 ± 0.00 | |
sham | 1.62 ± 0.10 | 1.01 ± 0.08 | 0.11 ± 0.01 | 0.07 ± 0.01 | |
Proestrus | 48 h | 1.88 ± 0.14 | 0.83 ± 0.02 | 0.11 ± 0.02 | 0.07 ± 0.01 |
2 w | 1.87 ± 0.09 | 0.88 ± 0.04 | 0.12 ± 0.01 | 0.08 ± 0.01 | |
Estrus | sham | 1.65 ± 0.09 | 0.81 ± 0.06 | 0.11 ± 0.01 | 0.07 ± 0.01 |
48 h | 1.76 ± 0.11 | 0.82 ± 0.03 | 0.10 ± 0.02 | 0.07 ± 0.01 | |
2 w | 1.74 ± 0.13 | 0.98 ± 0.18 | 0.12 ± 0.01 | 0.08 ± 0.02 | |
No differences were found in heart chambers weight index These results are the
mean |
We also measured hemodynamic parameters (systolic and diastolic blood pressure,
LVSP, LVDP, HR, and
Sex hormones attenuate hemodynamic changes after
myocardial infarction. (A) No differences were found in
systolic blood pressur (SBP). (B) No differences were found diastolic blood
pressure (DBP). (C) Left ventricular systolic pressure (LVSP) was higher in the
proestrus and estrus groups vs OVX (* p
When we quantified NO in samples obtained from the left ventricular penumbra (Fig. 3), we detected lower levels of NO in the OVX-2 w group compared to the OVX-sham group. No changes were found in the proestrus groups. The estrus-2 w CO group had higher levels than the estrus-sham group. On the other hand, the estrus and proestrus groups showed lower concentrations of NO than the OVX-sham and OVX-48 h groups, respectively. NO production was higher in the estrus and OVX groups at 2 weeks after CO, vs proestrus-2 w CO.
Effects of sex hormones on NO levels after
myocardial infarction. NO levels were lower in proestrus (* p
Finally, to relate the loss of hormones to oxidative stress, we quantified ROS in left ventricular penumbra samples (Fig. 4). OVX females showed a significant increase in ROS after 48 h and two weeks after CO compared to OVX-sham animals. Among the infarcted females in the proestrus and estrus phases, there were no significant differences in ROS levels along MI evolution. In the sham groups, lower levels of ROS were quantified in ovx females compared to females in the estrous and proestrus phases. In the 48 h CO groups, lower levels of ROS were observed in infarcted females in the estrus phase compared to females in the proestrus phase and OVX. there were no significant differences in the levels of ROS between groups at 2 weeks after CO.
The absence of sex hormones increases ROS levels after
myocardial infarction. Oxidative stress was higher in OVX after MI (* p
In this work we found that the extent of initial damage caused by CO, seems to be related to hormonal levels at the time of infarction. The cardioprotective effects of estrogens have been widely reported [26, 27, 28], nevertheless, previous studies that compared the incidence of MI between premenopausal and postmenopausal women only considered the presence and absence of estrogens as a determining factor [29, 30]. However, the influence of variations in this hormone throughout the estrous cycle has not been studied in acute or chronic MI. In this work we demonstrate the importance of estrogens variations during the post-infarction adaptive period. Our results are in agreement with Mukamal et al. [6] who, two decades ago, reported a threefold higher risk of MI during the early follicular phase in women when estrogen and progesterone levels are lower. However, the authors did not further investigate the underlying mechanisms or post-MI cardiovascular function. In this regard, we demonstrated that the estrous cycle phase during which the injury occurs, determines the severity of disease evolution. We propose that estrogens in the proestrus stage [31, 32], confer cardioprotection by reducing the infarction area, in addition to maintaining the contractile capacity of the left ventricle and preventing changes in NO and ROS levels.
Some investigations suggest that estrogens reduce decrease the infarction area
[15, 33, 34]. However, most of these studies involved exogenous administration of
hormones. In this work, we showed that physiological concentrations of sex
hormones during the proestrus phase may help to protect the heart during the
infarction process. The cardioprotective mechanisms are diverse. Pelzer
et al. [35], demonstrated in vitro that estrogens inhibit
apoptosis in cardiomyocytes, which may be related to a decrease in the activation
of caspase 3, a protein involved in this process [36]. As demonstrated with the
use of a specific ER
It is worth to mentioning that, in our study, none of the groups developed
cardiac hypertrophy as a consequence of MI. Some authors have found an increased
deposition of collagen in the myocardium after infarction in OVX females when the
post-infarction period was longer than ten weeks [40]. We believe that the
absence of cardiac hypertrophy is related to the systemic pressure values that
are maintained despite the infarction. Our results agree with some researchers
who have found no change in mean arterial pressure or systemic pressure at 2 or 6
weeks post-MI in OVX and non-OVX females [41]. On the other hand, the lower HR in
the OVX groups indicates that the loss of ovarian hormones has a direct impact on
this parameter. Jankowski et al. [42] 2001 reported a decrease of atrial
natriuretic peptide in OVX rats that was associated with a reduction in HR.
Supporting our results, Pinkham et al. [41] found a lower HR in OVX
females with and without infarction compared to those with intact ovaries. Also,
females with MI that received exogenous 17-
Moreover, we found lower LVSP and higher LVDP values in the OVX groups. Within
this context, Wan et al. [46] in 2014, demonstrated that the increase in
LVDP is an important early indicator of heart failure in humans. The rise in LVDP
after MI may indicate a decreased relaxation ability of the heart during
ventricular filling. In addition to ventricular pressures, relaxation and
contraction indexes expressed as –dP/dt and +dP/dt,
respectively, allow to estimate the contractile capacity of the ventricle [47].
Van Eickels in 2003 and Almeida in 2014 reported a decrease in the
Silberman et al. [52], in 2010, have associated the effect of MI on ventricular relaxation with oxidative stress and reduced activity/production of NOS/NO, suggesting that oxidative stress is a result of NOS decoupling. Previous investigations indicated that estradiol upregulates the expression and activity of eNOS in endothelial cells [14, 53]. Higher levels of estradiol increase NO production and represent one of the most important cardioprotective mechanisms at the vascular level in pathologies such as heart attack [54]. However, we obtained different results, NO levels were not modified in the proestrus phase but were higher in OVX females, suggesting that NO may exert different effects on the heart according to the enzyme that produces it. Future research is required to confirm this suggestion.
Sheng-an et al. [55], in 2016, have associated iNOS with the
development of inflammation in MI and observed an increase in NO. Thus, the NO
found in cardiac tissue may have been generated by iNOS in OVX females. Some
studies suggest that inflammatory factors can increase the infarction area and
LVDP, reduce LVSP, and promote ventricular remodeling, causing heart failure [56, 57]. Furthermore, Zancan et al. [58] demonstrated that 17-
On the other hand, it is known that, during infarction, oxygen deprivation
inhibits electron flow in mitochondria, rendering ATP use inefficient and turning
ATP synthase into an ATPase that consumes ATP to extrude protons from the matrix
to the intermembrane space [60, 61]. When ischemia is permanent, the
Na
Based on our results, we propose that oxidative stress is controlled if CO
occurs in the presence of sex hormones. Feng et al. [64] showed that
acute treatment with estradiol was able to close the PTPm through its GPER
receptor, activating the MERK/ERK signaling pathway that phosphorylates
GSK-3
In 2016, Luo et al. [65] reported a relationship between the expression
of estrogen receptors and the decrease in oxidative stress and infarcted area.
The authors attributed these effects to the upregulation of p38
The phase of the estrous cycle in which myocardial infarction occurs is important. When coronary occlusion occurs during proestrus, it prevents changes in cardiac function, the development of hypertrophy, oxidative stress and changes in NO levels, and reduces the extent of infarction.
Our work showed that ovarian hormones influence cardiac function in young Wistar rats; nevertheless, it is necessary to analyze the changes in ovarian hormones that occur during aging and how estrogen replacement therapy can improve survival in post-menopausal women. This could help to emphasize the importance of considering hormonal influences on cardiovascular diseases and encourage scientists to investigate sex differences in the causes, diagnosis, pathophysiology and treatments in this field.
JFM, DRH and PLS conceived and designed the experiments; DRH performed the experiments; JFM, DRH analyzed the data; SFC, MCRH contributed reagents and materials.
Local ethics committee approval was obtained with the informed consent of all participants. The institutional review board of the CICUAE-FESC approved the use of animals in this research project, code C18_06.
The authors thank C. Ramon Martínez-Gomez and Juan Martinez-Pariente from CINVESTAV-IPN Unidad Sur for providing the experimental animals.
This work was supported by grants from PAPIIT IN213318, PAPIIT IA205119, PIAPI 1828-FES Cuautitlan, Universidad Nacional Autonoma de México and CONACYT A1-S-8958.
The authors declare no conflict of interest.